These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12324500)

  • 21. Recombinant human activated protein C, heparin and melagatran in umbilical cord versus adult plasma.
    Koestenberger M; Cvirn G; Gallistl S; Kutschera J; Muntean W
    Acta Paediatr; 2005 Jul; 94(7):884-9. PubMed ID: 16188810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin.
    Eriksson BI; Agnelli G; Cohen A; Dahl O; Mouret P; Rosencher N; Panfilov S; Andersson M;
    Thromb Haemost; 2004 Aug; 92(2):428-30. PubMed ID: 15269843
    [No Abstract]   [Full Text] [Related]  

  • 23. No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
    Wåhlander K; Eriksson-Lepkowska M; Frison L; Fager G; Eriksson UG
    Clin Pharmacokinet; 2003; 42(8):755-64. PubMed ID: 12846596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
    Genzen JR; Miller JL
    Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
    Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
    J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lepirudin on the international normalized ratio.
    Stephens JL; Koerber JM; Mattson JC; Smythe MA
    Ann Pharmacother; 2005 Jan; 39(1):28-31. PubMed ID: 15590880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct thrombin inhibitors: pharmacology and clinical relevance.
    Kam PC; Kaur N; Thong CL
    Anaesthesia; 2005 Jun; 60(6):565-74. PubMed ID: 15918828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.
    Koestenberger M; Gallistl S; Cvirn G; Baier K; Leschnik B; Muntean W
    Thromb Res; 2005; 115(1-2):135-42. PubMed ID: 15567465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating platelet function with selective thrombin inhibitors.
    Verstraete M
    Haemostasis; 1996 Oct; 26 Suppl 4():70-7. PubMed ID: 8979113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia during major vascular surgery.
    Sun Y; Greilich PE; Wilson SI; Jackson MR; Whitten CW
    Anesth Analg; 2001 Feb; 92(2):344-6. PubMed ID: 11159229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model.
    Harenberg J; Zokai K; Piazolo L; Fenyvesi T; Jörg I
    Semin Thromb Hemost; 2002 Aug; 28(4):379-82. PubMed ID: 12244485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction.
    Siegmund R; Boer K; Poeschel K; Wolf G; Deufel T; Kiehntopf M
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):288-93. PubMed ID: 18469550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two different ecarin clotting time methods.
    Fenyvesi T; Harenberg J; Weiss C; Jörg I
    J Thromb Thrombolysis; 2005 Aug; 20(1):51-6. PubMed ID: 16133897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring direct thrombin inhibitors with routine and dedicated coagulation assays: which assay is helpful?
    Curvers J; van de Kerkhof D; Stroobants AK; van den Dool EJ; Scharnhorst V
    Am J Clin Pathol; 2012 Oct; 138(4):551-8. PubMed ID: 23010710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
    Harenberg J; Jörg I; Fenyvesi T; Piazolo L
    J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The first oral thrombin inhibitor. Competition to heparins and marcumar?].
    MMW Fortschr Med; 2003 Mar; 145(10):56. PubMed ID: 12688030
    [No Abstract]   [Full Text] [Related]  

  • 38. Old and new antithrombotic drugs in neonates and infants.
    Young G
    Semin Fetal Neonatal Med; 2011 Dec; 16(6):349-54. PubMed ID: 21816695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
    Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
    Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of the anticoagulants argatroban and lepirudin: a comparison of laboratory methods.
    Ivandic B; Zorn M
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):549-55. PubMed ID: 20834029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.